Industry News

Industry News

Chemotherapy enhanced by preventing cell repair in tumour cells

Feb 25, 2014

Chemotherapies are cancer treatments that work by inducing lesions in the DNA of tumour cells in order to inhibit their proliferation. However, the body naturally tries to repair these lesions, and thus reduces the efficacy of chemotherapy. Blocking the mechanisms for DNA repair would help to potentiate chemotherapy by reducing the resistance of cells to treatment. Read More

Rapid increase in chronic illnesses plus high rates of infectious disease faced by developing countries

Feb 25, 2014

Chronic illness, already a major and expensive problem in developed countries, is rapidly increasing in developing countries, adding to the longstanding burden caused by high rates of infectious diseases. Read More

Study of cell behaviour in low oxygen conditions has important implications for tumours

Feb 25, 2014

Research at the University of Liverpool has explained how cells behave when placed in a low oxygen environment, a development that could have implications for cancer patients and other serious illnesses.The research opens up the possibility of controlling the signals that keep cells alive, preventing the damages caused by ischemia - a restriction of blood supply to tissues. Read More

Increased risk of prostate cancer in some men taking selenium and vitamin E supplements

Feb 25, 2014

A multi-center study led by Fred Hutchinson Cancer Research Center has found that high-dose supplementation with both the trace element selenium and vitamin E increase the risk of high-grade prostate cancer. But importantly, this risk depends upon a man's selenium status before taking the supplements. Read More

Chemotherapy enhanced by preventing cell repair in tumour cells

Feb 25, 2014

Chemotherapies are cancer treatments that work by inducing lesions in the DNA of tumour cells in order to inhibit their proliferation. However, the body naturally tries to repair these lesions, and thus reduces the efficacy of chemotherapy. Blocking the mechanisms for DNA repair would help to potentiate chemotherapy by reducing the resistance of cells to treatment. Read More

Patient-Centered Outcomes Research Institute sets prioritized research agenda for managing two diverse conditions

Feb 24, 2014

Two articles being published in Annals of Internal Medicine seek to set prioritized research agendas to fill the evidence gaps about two diverse conditions - bipolar disorder in young people and ductal carcinoma in situ (DCIS) in women. Read More

Patient-Centered Outcomes Research Institute sets prioritized research agenda for managing two diverse conditions

Feb 24, 2014

Two articles being published in Annals of Internal Medicine seek to set prioritized research agendas to fill the evidence gaps about two diverse conditions - bipolar disorder in young people and ductal carcinoma in situ (DCIS) in women. Read More

New breakthrough for women with advanced cervical cancer, Avastin (bevacizumab) can extend lives

Feb 24, 2014

New data showing cancer treatment Avastin® (bevacizumab) can extend the lives of women with advanced cervical cancer compared to chemotherapy alone has been published in the New England Journal of Medicine. In the last decade the incidence of cervical cancer has risen by approximately 15% in the UK with 2,900 women diagnosed in 2010. Read More

Tissue-penetrating light releases chemotherapy inside cancer cells

Feb 24, 2014

Researchers from the cancer nanotechnology and signal transduction and therapeutics programs of UCLA's Jonsson Comprehensive Cancer Center (JCCC) have developed an innovative technique that can carry chemotherapy safely and release it inside cancer cells when triggered by two-photon laser in the infrared red wave length. Drs. Read More

Immune cells regulate blood stem cells

Feb 24, 2014

Researchers in Bern have discovered that, during a viral infection, immune cells control the blood stem cells in the bone marrow and therefore also the body's own defences. The findings could allow for new forms of therapy, such as for bone marrow diseases like leukaemia. Read More

Previous Page   Next Page